These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 30430197

  • 1. Molecular basis of primary hyperoxaluria: clues to innovative treatments.
    Dindo M, Conter C, Oppici E, Ceccarelli V, Marinucci L, Cellini B.
    Urolithiasis; 2019 Feb; 47(1):67-78. PubMed ID: 30430197
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical spectrum of primary hyperoxaluria type 1: Experience of a tertiary center.
    Soliman NA, Nabhan MM, Abdelrahman SM, Abdelaziz H, Helmy R, Ghanim K, Bazaraa HM, Badr AM, Tolba OA, Kotb MA, Eweeda KM, Fayez A.
    Nephrol Ther; 2017 May; 13(3):176-182. PubMed ID: 28161266
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Systemic Alanine Glyoxylate Aminotransferase mRNA Improves Glyoxylate Metabolism in a Mouse Model of Primary Hyperoxaluria Type 1.
    Kukreja A, Lasaro M, Cobaugh C, Forbes C, Tang JP, Gao X, Martin-Higueras C, Pey AL, Salido E, Sobolov S, Subramanian RR.
    Nucleic Acid Ther; 2019 Apr; 29(2):104-113. PubMed ID: 30676254
    [Abstract] [Full Text] [Related]

  • 6. Identification of a novel AGXT gene mutation in primary hyperoxaluria after kidney transplantation failure.
    M'dimegh S, Omezzine A, Hamida-Rebai MB, Aquaviva-Bourdain C, M'barek I, Sahtout W, Zellama D, Souche G, Achour A, Abroug S, Bouslama A.
    Transpl Immunol; 2016 Nov; 39():60-65. PubMed ID: 27568336
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Oxalobacter formigenes treatment combined with intensive dialysis lowers plasma oxalate and halts disease progression in a patient with severe infantile oxalosis.
    Pape L, Ahlenstiel-Grunow T, Birtel J, Krohne TU, Hoppe B.
    Pediatr Nephrol; 2020 Jun; 35(6):1121-1124. PubMed ID: 32107618
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Primary hyperoxaluria.
    Watts RW.
    Contrib Nephrol; 1997 Jun; 122():143-59. PubMed ID: 9399058
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1.
    Dutta C, Avitahl-Curtis N, Pursell N, Larsson Cohen M, Holmes B, Diwanji R, Zhou W, Apponi L, Koser M, Ying B, Chen D, Shui X, Saxena U, Cyr WA, Shah A, Nazef N, Wang W, Abrams M, Dudek H, Salido E, Brown BD, Lai C.
    Mol Ther; 2016 Apr; 24(4):770-8. PubMed ID: 26758691
    [Abstract] [Full Text] [Related]

  • 15. Hyperoxaluric calcium nephrolithiasis.
    Asplin JR.
    Endocrinol Metab Clin North Am; 2002 Dec; 31(4):927-49. PubMed ID: 12474639
    [Abstract] [Full Text] [Related]

  • 16. Molecular therapy of primary hyperoxaluria.
    Martin-Higueras C, Torres A, Salido E.
    J Inherit Metab Dis; 2017 Jul; 40(4):481-489. PubMed ID: 28425073
    [Abstract] [Full Text] [Related]

  • 17. Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter.
    Hatch M, Gjymishka A, Salido EC, Allison MJ, Freel RW.
    Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G461-9. PubMed ID: 21163900
    [Abstract] [Full Text] [Related]

  • 18. Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment.
    Cochat P, Hulton SA, Acquaviva C, Danpure CJ, Daudon M, De Marchi M, Fargue S, Groothoff J, Harambat J, Hoppe B, Jamieson NV, Kemper MJ, Mandrile G, Marangella M, Picca S, Rumsby G, Salido E, Straub M, van Woerden CS, OxalEurope.
    Nephrol Dial Transplant; 2012 May; 27(5):1729-36. PubMed ID: 22547750
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Targeting kidney inflammation as a new therapy for primary hyperoxaluria?
    Martin-Higueras C, Ludwig-Portugall I, Hoppe B, Kurts C.
    Nephrol Dial Transplant; 2019 Jun 01; 34(6):908-914. PubMed ID: 30169827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.